Skip to main content

Table 1 Grouping and treatment of experimental pigs

From: Comparative efficacy of experimental inactivated and live-attenuated chimeric porcine circovirus (PCV) 1-2b vaccines derived from PCV1 and PCV2b isolates originated in China

Group Vaccine Vaccine dose (TCID50) Vaccination day Challenge dose (TCID50) Challenge day
1 Live-attenuated PCV1-2b 2 × 103.5 21 2 × 104.8 49
2 Live-attenuated PCV1-2b 2 × 104.0 21 2 × 104.8 49
3 Inactivated PCV1-2b vaccine 2 × 105.0 21 2 × 104.8 49
4a Inactivated PCV2b vaccine X 2 ml 21 2 × 104.8 49
5 Challenge without vaccination - - 2 × 104.8 49
6 Mock group - - - -
  1. aOne pig died after routine bleeding at 7 DPV due to massive hemorrhaging